DEVELOPMENT OF A COMPUTERIZED NASAL RESISTANCE SYSTEM

计算机化鼻阻力系统的开发

• 批准号: 3508599
• 负责人: RICHARD FRYE
• 金额: $ 16.94万
• 依托单位: SENSONICS INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 1988
• 资助国家: 美国
• 起止时间: 1988-08-01 至 1991-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3508599
• 关键词: clinical biomedical equipment; computer assisted diagnosis; computer graphics /printing; computer human interaction; computer system design /evaluation; computers; human subject; mathematical model; model design /development; respiratory airflow measurement; respiratory airway pressure; respiratory hypersensitivity; statistics /biometry

Despite the fact that hundreds of thousands of Americans suffer from allergies, asthma, polyposis, and other airway restricting maladies, there is presently no low cost commercially available integrated computerized system for quantitatively assessing nasal airflow function. Quantitative normative data based upon male and female subjects with normal or abnormal nasal function are not available for any airflow measures derived from currently available commercial systems, and all such systems suffer from a number of technical and theoretical problems. The overall purpose of this project is to develop, for subsequent commercial distribution, a low cost, practical, and integrated computerized rhinomanometric system for which valid normative data are available, and percentile normative values are reported for patients at the time of testing based upon gender, age, and race. In Phase I we initiated the development of this system. In Phase II we will complete the development of this system and establish population norms for individuals with normal and abnormal nasal function. During Phase III the developed system will be made available for commercial distribution.

尽管成千上万的美国人 过敏、哮喘、息肉病和其他呼吸道限制 疾病，目前没有低成本的商业可用的 用于定量评估鼻的集成计算机化系统 气流功能 基于男性和 鼻功能正常或异常的女性受试者不 适用于从当前可用的 商业系统，并且所有这样的系统都遭受许多缺陷。 技术和理论问题。 这件事的总体目的是 该项目旨在为随后的商业发行开发一个 低成本、实用、集成化的计算机化测压仪 可获得有效规范性数据系统，以及百分位数 在检测时报告患者的标准值 基于性别年龄和种族 在第一阶段，我们启动了 这个系统的发展。 在第二阶段，我们将完成 制定这一制度，并建立人口标准， 鼻功能正常和异常的人。 在阶段 三、开发的系统将用于商业 分布